Eric Zudak, CEO of Thalocan Research Innovations, discusses Thalocan’s role in helping to address unmet needs in the immunodermatology area. With many, if not most inflammatory skin diseases being more common in Skin of Color than in lighter pigmented skin – Thalocan is proud to provide cutting edge technology, training and tools for more accurate scientific…
We are very excited to share our UPDATED comprehensive VASI training course! Authored by Dr. Iltefat Hamzavi, this enhanced training was designed by Thalocan Research Innovations to improve efficiency in clinical trial training management and support consistent severity assessment in #vitiligostudies. Please contact licensing@thalocan.com for details.
Looking forward to (nearly all of) our Thalocan Research Innovations Team meeting friends old and new at SHSA 2025 in Nashville, where we are a proud Bronze Sponsor! We have put a great deal of time and energy towards solutions to improve data quality, as well as patient experience and Investigator satisfaction. SHSA 2025 will…
Dr. Amit Garg shares his experience with the unique challenges of disease assessment and measuring treatment response in Hidradenitis Suppurativa. At Thalocan Research Innovations we collaborate with experts like Dr. Garg and Dr. John Ingram, among others, to develop tools and applications that improve the experience for trialists and patients, as well as optimizing the…
